Hillhouse Investment Management, Ltd.

Hillhouse Investment Management, Ltd. is listed in filings as 10% Owner at ArriVent BioPharma, Inc.. This profile follows SEC Form 4 activity through Feb 3, 2026, including sale activity. Recent filings connect the profile to ArriVent BioPharma, Inc. (AVBP). The current snapshot covers public activity from Feb 3, 2026. Reported amounts are shown as $13.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.